换一批
换一批High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.
作者：
关键词
3DRT, three-dimensional radiation therapyADT, androgen deprivation therapyBT, brachytherapyBoostBrachytherapyCSS, cancer specific survivalCT, computerized tomographyCTCAE, common terminology criteria for adverse eventsCTV, clinical target volumeComorbidityD100, dose delivered to 100 of CTVD2cc, dose delivered to 2cc of the organ at riskD90, dose delivered to 90 of the clinical target volumeDFS, disease-free survivalDNR, dose non-homogeneity ratioEBRT, external beam radiation therapyEQD2, equivalent dose at 2 Gy per fractionElderyGI, gastro-intestinalGU, genito-urinaryHDB, high-dose rate brachytherapyHR, high riskHigh-riskIMRT, intensity modulated radiation therapyIR, intermediate riskISUP, International Society of Urological PathologyLDR, low dose-rateLR, low riskMFU, median follow upMRI, magnetic resonance imagingNCCN, national comprehensive cancer networkOAR, organs at risksOS, overall survivalOncogeriatric assessmentPC, prostate cancerPET, positron emission tomographyPSA, prostate specific antigenProstate cancerQoL, quality of lifeRCT, randomized clinical trialTD, total doseV100, percentage of the clinical target volume receiving 100 of the prescribed doseV150, percentage of the clinical target volume receiving 150 of the prescribed doseV200, percentage of the clinical target volume receiving 200 of the prescribed doseVr100, percentage of the rectum volume receiving 100 of the prescribed doseVr90, percentage of the rectum volume receiving 90 of the prescribed doseVu115, percentage of the urethra volume receiving 115 of the prescribed doseVu125, percentage of the urethra volume receiving 125 of the prescribed dosebRFS, biochemical relapse free survivallRFS, local relapse free survivalmRFS, metastatic relapse-free survivalpts, patientsrRFS, regional lymph-node relapse free survival
DOI
10.1016/j.ctro.2022.05.001
PMID
35692263
发布时间
2022-07-16
- 浏览2
Clinical and translational radiation oncology
2022年35卷
104-109页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
